Improving patient outcomes with robotic-assisted microsurgery
Explore our other Clinical Applications
Breast Cancer Overview
Whether it’s deciding on a reconstructive procedure following mastectomy or dealing with the possibility of developing lymphedema as a result of their care, breast cancer patients face a significant uphill battle after their treatment. With Symani, patients can access reconstructive options using their own tissue and the latest technological innovations. For hospitals offering surgical treatment options for lymphedema, they may also be able to prevent or treat the symptoms of lymphedema following their care.
Lymphedema, the build-up of lymphatic fluid resulting in swelling and discomfort, affects over 250 million people worldwide*. Surgical treatment options may improve the symptoms and overall quality of life for these patients, but access to these treatments is limited. This is mainly due to procedural complexity associated with the size of lymphatic vessels. With 7-20x motion scaling and tremor filtration, the Symani Surgical System is designed to enable supermicrosurgical procedures such as lymphovenous anastomosis or bypass (LVA/LVB).
Head & Neck Cancer Overview
The incidence of head and neck cancers is on the rise and increasing the need for reconstructive procedures that utilize microsurgical techniques. Reconstruction of the head and neck following tumor resection or trauma can help restore function and improve quality of life for patients. With Symani, surgeons can perform these challenging and complex procedures with a high degree of precision and control in an optimized work environment.
Are you ready to open up new surgical treatment options?
Use the form to submit your contact details and we will get in touch with you.
- Limb Loss and Limb Difference Awareness Month (2023). Retrieved from https://www.amputee-coalition.org/events-programs/limb-loss-awareness-month/
- McDonald CL, Westcott-McCoy S, Weaver MR, Haagsma J, Kartin D. Global prevalence of traumatic non-fatal limb amputation. Prosthet Orthot Int. 2021 Apr 1;45(2):105-114.
- Cho, H. E., Kotsis, S. V., & Chung, K. C. (2019). Outcomes Following Replantation/Revascularization in the Hand. Hand clinics, 35(2), 207–219.
The Symani Surgical System is a CE marked (CE 0051) medical device and is not approved or cleared by the FDA for commercial use in the U.S.
© 2023 Medical Microinstruments, Inc. All Rights Reserved.